Cov-21c

N/A

Report date: 2025/01/26 17:21:12
NME

Base Information

Drug NameCov-21c
Drug Alias Nameandrogen receptor antagonist (University of Tennessee Health Science Center)covalent AR/AR-V7 inhibitor (University of Tennessee Health Science Center)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAndrogen Receptor degraders
TargetsAndrogen Receptor
Therapy Area/IndicationsHormone-Resistant Prostate Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Tennessee Health Science Center
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Tennessee Health Science Center
Inactive CompaniesN/A
Active IndicationsHormone-Resistant Prostate Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A